Leading Cannabis Doctor Joins Nuvilex
December 31st, 2013
News, Top Story
Dr. Mark L. Rabe, former Chief Medical Officer of California’s largest network of physician-owned medical cannabis evaluation centers, recently joined Nuvilex Inc.’s (OTCQB: NVLX) Scientific Advisory Board in a move that could suggest the company is close to starting medical marijuana research.
Read the full press release discussing the new appointment here:
Nuvilex, Inc. (OTCQB: NVLX) upped the ante this month in the field of medical marijuana when it appointed Dr. Mark L. Rabe as Chairman of its Subsidiary’s Scientific Advisory Board at Medical Marijuana Sciences, Inc. Dr. Rabe is a leading figure in the fast growing sector, and much like when Dr. Gerald Crabtree was named Nuvilex COO, this appointment shows just how serious the company is to be the best in the industry.
The question now is how close Nuvilex is to starting its medical marijuana research, and is this appointment the first step in activating Medical Marijuana Sciences? Nuvilex’s efforts to establish itself as a player in the biotechnology industry are made even clearer with an appointment of this magnitude.
Dr. Rabe was Chief Medical Officer of California’s largest network of physician-owned medical cannabis evaluation centers. In that position, he helped provide over 100,000 medical cannabis recommendations to patients in 20 different clinics across the state. According to his colleagues, every recommendation did what it was supposed to do: “protect patients and provide them with access to an herbal medicine that improves their health and their lives.”
Nuvilex stated in a recent press release that while a part of the network, Dr. Rabe hired and trained medical personnel, organized public educational symposia and media outreach. Dr. Rabe is also the founder and medical director of Centric Wellness, a medical practice in San Diego that offers natural health care services to attain optimal health and manage chronic medical conditions.
In addition, Dr. Rabe serves as the CEO of Green Medical Solutions, LLC, which offers educational programs and practice management consulting services to health care practitioners. Clearly with his 25+ years of practice experience, Dr. Rabe is no stranger to the medical marijuana arena. His expertise dealing with the drug and many thousands of patients in need of its benefits will serve Nuvilex and its shareholders well as research begins.
About Stock Market Media Group
SMMG is a full service IR firm specializing in Research and Content Development. It offers a platform for corporate stories to unfold through the media with Reports, Interviews and Articles. For more information and to read disclaimers and disclosures:www.stockmarketmediagroup.com.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.